Survival Outcomes of Nonsmall Cell Lung Cancer Patients Treated with Afatinib Who Are Affected by Early Adverse Events

Figure 1

Kaplan–Meier estimates of OS and PFS by the maximum grade of rash within the first 28 days of afatinib treatment.

(a)

(b)